Association between polymorphisms of arachidonate 12-lipoxygenase (ALOX12) and schizophrenia in a Korean population

Behavioral and Brain Functions

Volumn 6, Issue , 2010, Pages

  Kim, Tae ^a,b   Kim, Hak Jae ^c   Park, Jin K ^d   Kim, Jong W ^a   Chung, Joo Ho ^a  

^a Kyung Hee University Hospital   (South Korea)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Soonchunhyang University   (South Korea)

^d Kyung Hee University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ALOX12 PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; FACTORIAL ANALYSIS; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN; BIOLOGICAL MODEL; CASE CONTROL STUDY; DNA SEQUENCE; GENE LINKAGE DISEQUILIBRIUM; GENETICS; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY;

ADULT; ARACHIDONATE 12-LIPOXYGENASE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FACTOR ANALYSIS, STATISTICAL; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; KOREA; LINKAGE DISEQUILIBRIUM; MALE; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEQUENCE ANALYSIS, DNA;

EID: 77954529978     PISSN: 17449081     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-9081-6-44     Document Type: Article

References (23)

1. Horrobin DF. The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophr Res 1998, 30:193-208. 10.1016/S0920-9964(97)00151-5, 9589514.
2. Ward PE, Sutherland J, Glen EM, Glen AI. Niacin skin flush in schizophrenia: a preliminary report. Schizophr Res 1998, 29:269-74. 10.1016/S0920-9964(97)00100-X, 9516668.
3. Yoshimoto T, Yamamoto Y, Arakawa T, Suzuki H, Yamamoto S, Yokoyama C, Tanabe T, Toh H. Molecular cloning and expression of human arachidonate 12-lipoxygenase. Biochem Biophys Res Commun 1990, 172:1230-5. 10.1016/0006-291X(90)91580-L, 2244907.
4. Piomelli D, Wang JK, Sihra TS, Nairn AC, Czernik AJ, Greengard P. Inhibition of Ca2+/calmodulin-dependent protein kinase II by arachidonic acid and its metabolites. Proc Natl Acad Sci USA 1989, 86:8550-4. 10.1073/pnas.86.21.8550, 298320, 2554319.
5. Fujisawa H, Okuno S. Regulation of the activity of tyrosine hydroxylase in the central nervous system. Adv Enzyme Regul 1989, 28:93-110. 10.1016/0065-2571(89)90066-6, 2576179.
6. Piomelli D, Greengard P. Lipoxygenase metabolites of arachidonic acid in neuronal transmembrane signalling. Trends Pharmacol Sci 1990, 11:367-73. 10.1016/0165-6147(90)90182-8, 2122564.
7. American Psychiatric Association Diagnostic and statistical manual of mental disorders. 1994, Washington, DC: American Psychiatric Press, 4, American Psychiatric Association.
8. McGuffin P, Farmer A, Harvey I. A polydiagnostic application of perational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch Gen Psychiatry 1991, 48:764-70.
9. Rickham PP. Human Experimentation. Code of Ethics of the World Medical Association. Declaration of Helsinki. Br Med J 1964, 2:177. 10.1136/bmj.2.5402.177, 1816102, 14150898.
10. Sole X, Guino E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006, 22:1928-9. 10.1093/bioinformatics/btl268, 16720584.
11. Brash AR. Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J Biol Chem 1999, 274:23679-82. 10.1074/jbc.274.34.23679, 10446122.
12. Li Y, Maher P, Schubert D. A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron 1997, 19:453-63. 10.1016/S0896-6273(00)80953-8, 9292733.
13. Pratico D, Zhukareva V, Yao Y, Uryu K, Funk CD, Lawson JA, Trojanowski JQ, Lee VM. 12/15-lipoxygenase is increased in Alzheimer's disease: possible involvement in brain oxidative stress. Am J Pathol 2004, 164:1655-62. 1615676, 15111312.
14. Davis KL, Kahn RS, Ko G, Davidson M. Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 1991, 148:1474-86.
15. Goodman JE, Bowman ED, Chanock SJ, Alberg AJ, Harris CC. Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk. Carcinogenesis 2004, 25:2467-72. 10.1093/carcin/bgh260, 15308583.
16. Gong Z, Hebert JR, Bostick RM, Deng Z, Hurley TG, Dixon DA, Nitcheva D, Xie D. Common polymorphisms in 5-lipoxygenase and 12-lipoxygenase genes and the risk of incident, sporadic colorectal adenoma. Cancer 2007, 109:849-57. 10.1002/cncr.22469, 17236225.
17. Tan W, Wu J, Zhang X, Guo Y, Liu J, Sun T, Zhang B, Zhao D, Yang M, Yu D, Lin D. Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer. Carcinogenesis 2007, 28:1197-1201. 10.1093/carcin/bgl242, 17151091.
18. Jiang WG, Douglas-Jones A, Mansel RE. Levels of expression of lipoxygenases and cyclooxygenase-2 in human breast cancer. Prostaglandins Leukot Essent Fatty acids 2003, 69:275-81. 10.1016/S0952-3278(03)00110-8, 12907138.
19. Mohammad AM, Abdel HA, Abdel W, Ahmed AM, Wael T, Eiman G. Expression of cyclooxygenase-2 and 12-lipoxygenase in human breast cancer and their relationship with HER-2/neu and hormonal receptors: impact on prognosis and therapy. Indian J Cancer 2006, 43:163-8. 10.4103/0019-509X.29421, 17192687.
20. Kandouz M, Nie D, Pidgeon GP, Krishnamoorthy S, Maddipati KR, Honn KV. Platelet-type 12-lipoxygenase activates NF-kappaB in prostate cancer cells. Prostaglandins Other Lipid Mediat 2003, 71:189-204. 10.1016/S1098-8823(03)00042-X, 14518561.
21. Nie D, Nemeth J, Qiao Y, Zacharek A, Li L, Hanna K, Tang K, Hillman GG, Cher ML, Grignon DJ, Honn KV. Increased metastatic potential in human prostate carcinoma cells by overexpression of arachidonate 12-lipoxygenase. Clin Exp Metastasis 2003, 20:657-63. 10.1023/A:1027302408187, 14669797.
22. Matsuyama M, Yoshimura R, Mitsuhashi M, Hase T, Tsuchida K, Takemoto Y, Kawahito Y, Sano H, Nakatani T. Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors. Int J Oncol 2004, 24:821-7.
23. Yoshimura R, Matsuyama M, Tsuchida K, Kawahito Y, Sano H, Nakatani T. Expression of lipoxygenase in human bladder carcinoma and growth inhibition by its inhibitors. J Urol 2003, 170:1994-9. 10.1097/01.ju.0000080296.54262.c8, 14532840.